Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus Macbeth

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Blood Advances|February 11, 2021
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerGary H Lyman, Marc Carrier, Cihan Ay, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2020
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysisNick van Es, Matthew Ventresca, Marcello Di Nisio, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Blood Advances|February 11, 2021
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerGary H Lyman, Marc Carrier, Cihan Ay, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2020
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysisNick van Es, Matthew Ventresca, Marcello Di Nisio, et al.
Pageof 12